Advertisement

Topics

BRIEF—Inozyme Pharma to use $49 million funding to progress rare disease pipeline

08:58 EST 15 Nov 2017 | thePharmaLetter

US biotech firm Inozyme Pharma today announced it has raised a $49 million Series A financing. The financing…

Original Article: BRIEF—Inozyme Pharma to use $49 million funding to progress rare disease pipeline

NEXT ARTICLE

More From BioPortfolio on "BRIEF—Inozyme Pharma to use $49 million funding to progress rare disease pipeline"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...